Abivax (ABVX) Income from Continuing Operations (2022 - 2026)

Abivax (ABVX) has reported Income from Continuing Operations for 5 consecutive years, with 56209840.15 the latest figure, recorded in Q1 2026.

• In Q1 2026, Income from Continuing Operations fell 2.04% year-over-year to 56209840.15; the TTM figure through Mar 2026 stood at 372196260.79 (down 86.54% YoY), while the FY2025 annual figure was 377732120.52, down 100.62% from the prior year.
• Income from Continuing Operations came in at 56209840.15 for Q1 2026 at Abivax, up from 81899773.61 in the prior quarter.
• The five-year high for Income from Continuing Operations was 41750931.33 in Q2 2024, with the low at 179283950.7 in Q3 2025.
• Average Income from Continuing Operations over 5 years is 74679623.72, with a median of 56209840.15 recorded in 2026.
• Across the five-year window, Income from Continuing Operations surged 69.33% in 2024 and tumbled 195.6% in 2025, its largest moves.
• Year by year, Income from Continuing Operations stood at 66112029.27 in 2022, then slumped by 107.34% to 137074744.4 in 2023, then soared by 69.33% to 42034268.66 in 2024, then plunged by 94.84% to 81899773.61 in 2025, then jumped by 31.37% to 56209840.15 in 2026.
• According to Business Quant data, Income from Continuing Operations over the past three periods registered 56209840.15, 81899773.61, and 179283950.7 for Q1 2026, Q4 2025, and Q3 2025 respectively.